【摘 要】
：
Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells (MSC) to secrete brain-derived neurotrophic factor
【机 构】
：
Stem Cell Program and Institute for Regenerative Cures, University of California Davis Health System
论文部分内容阅读
Progress to date from our group and others indicate that using genetically-engineered mesenchymal stem cells (MSC) to secrete brain-derived neurotrophic factor (BDNF) supports our plan to submit an Investigational New Drug application to the Food and Drug Administration for the future planned Phase 1 safety and tolera-bility trial of MSC/BDNF in patients with Huntington’s disease (HD). There are also potential applications of this approach beyond HD. Our biological delivery system for BDNF sets the precedent for adult stem cell ther-apy in the brain and could potentially be modiifed for other neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), spinocerebellar ataxia (SCA), Alzheimer’s disease, and some forms of Parkinson’s dis-ease. The MSC/BDNF product could also be considered for studies of regeneration in traumatic brain injury, spinal cord and peripheral nerve injury. This work also provides a platform for our future gene editing studies, since we will again use MSCs to deliver the needed molecules into the central nervous system.
其他文献
The optic nerve is a viscoelastic solid-like biomaterial. Its normal stress relaxation and creep properties enable the nerve to resist constant strain and prote
Although some patients have successful peripheral nerve regeneration, a poor recovery of hand function often occurs after peripheral nerve injury. It is believe
Pudendal nerve plays an important role in urine storage and voiding. Our hypothesis is that a neuroprosthetic device placed in the puden-dal nerve trunk can mod
Nerve regeneration conditioned lfuid is secreted by nerve stumps inside a nerve regeneration chamber. A better understanding of the pro-teinogram of nerve regen
目的探讨切割修复交叉互补基因2(excision repair cross-complementing rodent repair deficiency gene 2,ERCC2)在人脑胶质瘤耐药中的作用.方法采用来自p2E-ER2的2.4 kbEcoR
“确保所发表的报告无偏倚、准确地重现研究是每一位参与者的责任”[1].rn研究记录常常会做简化处理,但却存在对患者不利的风险.因此,医学研究界需要变革来保证读者获得所有
患者,男,34岁.因双下肢无力3月,加重20d于2001年10月入院.患者于入院前3个月出现双下肢无力、僵硬,行走不稳,伴全身乏力厌油,近20天出现渐进性行走困难就诊.无肢体疼痛、麻木
目的 探讨听神经瘤显微手术保留听神经功能及其影响因素。方法 收集我院近 2年来 2 3例经枕下乙状窦后入路显微手术的初发听神经瘤资料 ,其中包括肿瘤大小、术前术后听力、
Alzheimer’s disease (AD), a fatal progressive neurodegenerative disorder, has no cure to date. One of the causes of AD is the accumulation of amyloid-beta 42 (
目的 探讨中央性神经细胞瘤 (CN)的诊断、治疗及预后。方法 回顾分析我科 1 993～ 2 0 0 0年收治的1 7例CN的临床资料。结果 1 7例患者发病年龄从 1 7到 47岁不等 ,平均 31